Latest close we have: $3.46 on Oct 7, 2026. Fund positions use it until a newer close arrives.

GALMED PHARMACEUTICALS LTD
GLMD institutional ownership changes in Q2 2026: 3 institutions opened or added positions, 6 trimmed or exited. GLMD (GALMED PHARMACEUTICALS LTD) is held by 10 institutional investors as of Q2 2026. Top institutional shareholders: Citadel Advisors LLC ($48,315), HRT Financial LP ($23,000), XTX Topco Ltd ($8,353). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Oct 7, 2026 · Insiders none · Activists Nov 7, 2025 · Congress none
Top Holders
| Filer | Stake | Filed |
|---|---|---|
| CVI Investments, Inc. | 3.1% |
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about GLMD
Who owns GLMD?
10 institutional investors held GLMD on June 30, 2026, led by Citadel Advisors LLC ($48,315), HRT Financial LP ($23,000) and XTX Topco Ltd ($8,353).
How many hedge funds hold GLMD?
10 institutional investors reported GLMD in their 13F filings for the quarter ended June 30, 2026, $79,737 in all. One of them is rated Elite.
Are institutions buying or selling GLMD?
Selling, on balance. In Q2 2026, 6 institutions trimmed or exited GLMD and 3 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer